Increased frequency of micronuclei in diabetes mellitus patients using pioglitazone and glimepiride in combination

Food and Chemical Toxicology

Volumn 48, Issue 12, 2010, Pages 3432-3435

  Shaik, Noor Ahmad ^a,d   Shaik, Jilani Purusottapatnam ^b,c,d   Ali, Sharique ^b   Imran, Ahamad ^d   Rao, Durga Koteswara ^a  

^a OSMANIA UNIVERSITY   (India)

^b Sofia College   (India)

^c Shadan Institute for PG Studies   (India)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Combination therapy; Genotoxicity; Glimepiride; Micronuclei; Pioglitazone; Type 2 diabetes mellitus

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; GLIMEPIRIDE PLUS PIOGLITAZONE; GLUCOSE; HEMOGLOBIN A1C; MALACHITE GREEN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLUE COLLAR WORKER; BODY MASS; CELL SCREENING; CHEEK MUCOSA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EATING HABIT; FEMALE; FEULGEN STAINING; GENOTOXICITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; MOUTH CAVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RURAL AREA; SEX DIFFERENCE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA; WHITE COLLAR WORKER;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; DRUG THERAPY, COMBINATION; EPITHELIAL CELLS; FEMALE; GENETIC MARKERS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES;

RATTUS;

EID: 78049445549     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.09.016     Document Type: Article

References (30)

1. Abdulkerim B., Yuksel A., Birsen B., Zafer Y., Mehmet U., Duygu E.S., Ali O., Hakki K., Murat H.K., Muhlise A. Assessment of genotoxicity in rats treated with the antidiabetic agent, pioglitazone. Environ. Mol. Mutagen. 2008, 49:185-191.
2. Alba H., Noel X., Sara G., Antonia V., Amadeu C., Jordi S., Pere G., Ricardo M. Basal and induced micronucleus frequencies in human lymphocytes with different GST and NAT2 genetic backgrounds. Mutat. Res. 2006, 606:12-20.
3. Attia S.M., Helal G.K., Alhaider A.A. Assessment of genomic instability in normal and diabetic rats treated with metformin. Chem. Biol. Interact. 2009, 180(2):296-304.
4. Belien J.A., Copper M.P., Braakhuis B.J., Snow G.B., Baak J.P. Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells. Carcinogenesis 1995, 16(10):2395-2400.
5. Blasiak J., Arabski M., Krupa R., Wozniak M.Z., Kasznicki J., Zurawska M., Zurawska M., Drzewoski J. DNA damage and repair in type 2 diabetes mellitus. Mutat. Res. 2004, 554:297-304.
6. Bonassi S., Znaor A., Ceppi M., Lando C., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Cebulska-Wasilewska A., Fabianova E., Fucic A., Hagmar L., Joksic G., Martelli A., Migliore L., Mirkova E., Scarfi M.R., Zijno A., Norppa H., Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007, 28(3):625-631.
7. Day C. Thiazolidinediones: a new class of antidiabetic drugs. Diabet. Med. 1999, 16:179-192.
8. Duffaud F., Orsiere T., Baciuchka-Palmaro M., Digue L., Favre R., Botta A. Doxorubicin and cisplatin genotoxicity: search for a real indication using the micronucleus test. Ann. Biol. Clin. (Paris) 1998, 56(2):183-187.
9. Holland N., Bolognesi C., Kirsch-Volders M., Bonassi S., Zeiger E., Knasmueller S., Fenech M. The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: the HUMN project perspective on current status and knowledge gaps. Mutat. Res. 2008, 659(1-2):93-108.
10. Jenssen C., Ramel C. The micronucleus test as a part of a short-term mutagenicity test program for the prediction of carcinogenicity evaluated by 143 agents test. Mutat. Res. 1980, 75:191-202.
11. Jones T.A., Santter M., Van-Gaal L.F., Jones N.P. Addition of rosiglitazone to metformin is most effective in mice, insulin-resistant patients with type 2 diabetes. Diabetes Obes. Metab. 2003, 5:163-170.
12. Kahn C.R., Chen L., Cohen S.E. Unraveling the mechanism of action of thiazolidinediones. J. Clin. Invest. 2000, 106:1305-1307.
13. Kar R.N., Mukherjee B., Mukherjee S.K. Mutagenic evaluation of tolbutamide and glybenclamide on the bone marrow cells of mice. Toxicol. Lett. 1986, 34(2-3):153-157.
14. Krauss H., Kozlik J., Grzymislawski M., Sosnowski P., Mikrut K., Piatek J., Paluszak J. The influence of glimepiride on the oxidative state of rats with streptozotocin-induced hyperglycemia. Med. Sci. Monit. 2003, 9(11):389-393.
15. Leal-Garza C.H., Cerda-Flores R.M., Leal-Elizondo E., Cortes-Gutierrez E.I. Micronuclei in cervical smears and peripheral blood lymphocytes from women with and without cervical uterine cancer. Mutat. Res. 2002, 51:557-562.
16. Maiese K., Morhan S.D., Chong Z.Z. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr. Neurovasc. Res. 2007, 4:63-71.
17. Martino-Roth M.G., Viegas J., Roth D.M. Occupational genotoxicity risk evaluation through the comet assay and the micronucleus test. Genet. Mol. Res. 2003, 2(4):410-417.
18. Mohan V., Deepa M., Deepa R., Shanthirani C.S., Farooq S., Ganesan A., Datta M. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India. the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 2006, 49:1175-1178.
19. Mohan V., Sandeep S., Deepa R., Shah B., Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J. Med. Res. 2007, 125:217-230.
20. Narayanan P.K., Hart T., Elcock F., Zhang C., Hahn L., McFarland D., Schwartz L., Morgan D.G., Bugelski P. Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment. Cytometry A 2003, 52(1):28-35.
21. Nersesyan A., Kundi M., Atefie K., Schulte-Hermann R., Siegfried Knasmüller Effect of staining procedures on the results of micronucleus assays with exfoliated oral mucosa cells. Cancer Epidemiol. Biomarkers Prev. 2006, 15(10):1835-1840.
22. Norbert H., Kleinsasser Peter D., Rainer S., Ulrich A., Harreus Barbara, Wallner C. Genotoxic effects of vanadium pentoxide on human peripheral lymphocytes and mucosal cells of the upper aerodigestive tract. Int. J. Environ. Health Res. 2003, 13(4):373-379.
23. Rabbani S.I., Devi K., Khanam S. Inhibitory effect of glimepiride on the nicotinamide-streptozotocin induced nuclear damages and sperm abnormalities in diabetic Wistar rats. Indian J. Exp. Biol. 2009, 47(10):804-810.
24. Rehman A., Nourooz-Zadeh J., Moller W., Tritschler H., Pereira P., Halliwell B. Increased oxidative damage to all DNA bases in patients with type-II diabetes mellitus. FEBS Lett. 1999, 448(1):120-122.
25. Rekhadevi P.V., Sailaja N., Chandrasekhar M., Mahboob M., Rahman M.F., Grover Paramjit. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Mutagenesis 2007, 22(6):395-401.
26. Sawada, F., Inoguchi, T., Tsubouchi, H., Sasaki, S., Fujii, M., Maeda, Y., Morinaga, H., Nomura, M., Kobayashi, K., Takayanagi, R., 2008. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582. 57 (8), 1038-1045.
27. Simona S., Yves G., Chakradhar V., Hanna E.A., Samy L.H. Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and down regulation of DNA repair enzyme 8-oxo-7, 8-dihydro-2′-deoxyguanosine-DNA glycosylase. Diabetes 2009, 57:2626-2636.
28. Susana P., Amadeu C., Noel X., Csaba S., Ricard M. Occupational exposure to pesticides and cytogenetic damage: results of a Hungarian population study using the micronucleus assay in lymphocytes and buccal cells. Environ. Mol. Mutagen. 2002, 40(2):101-109.
29. Ten Cate A.R., Ten Cate R., Copelad E. Oral Histology: Development, Structure and Function 1998, Mosby-Year Book, St. Louis, MO.
30. Tolbert P.E., Shy C.M., Allen J.W. Micronuclei and other nuclear abnormalies in buccal smears: methods development. Mutat. Res. 1992, 271(1):69-77.